A Study of PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Clinical trial NCT03336580 · TERMINATED
Trial details
- NCT number
- NCT03336580
- Sponsor
- Prothena Biosciences Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-05
- Primary completion
- 2020-07-23
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.